Skip to main content

Advertisement

Log in

Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Breast cancer remains the most frequently diagnosed malignancy among women worldwide, with rising incidence numbers. In Belgium, one out of eight women will be diagnosed with breast cancer. Fortunately, 80% of those breast cancer patients will still be alive 10 years after diagnosis due to improvements in screening and treatment strategies. However, an important portion of the breast cancer survivors (BCS) will face side effects, such as sleep disturbances, long after treatment ends. It has been demonstrated that untreated insomnia in BCS negatively impacts mood, physical symptoms, pain sensitivity, fatigue, and quality of life. Furthermore, insomnia is increasingly considered an independent risk factor for future depression in BCS. The importance of understanding sleep disturbances in cancer populations has been highlighted and recognized as warranting further research. Therefore, the purpose of this systematic review was to determine the prevalence and the risk factors for the development of sleep disturbances in BCS.

Methods

PubMed, Web of Science, and PEDro were systematically screened for studies encompassing data regarding the prevalence or risk factors of sleep disturbances in BCS. If possible, meta-analyses were performed. Subgroup analyses were undertaken based on the methodological quality, study design, type of sleep disturbance, and the use of a measurement tool with strong psychometric properties to investigate significant heterogeneity (I2 > 50%) across studies.

Results

A total of 27 studies were found eligible. The pooled estimate for sleep disturbances prevalence is 0.40 (95% confidence interval (CI) = [0.29–0.52], I2 = 100%, p < 0.00001) and ranged from 0.14 (95% CI = [0.04–0.24]) to 0.93 (95% CI = [0.91–0.95]). Subgroup analyses did not reduce the heterogeneity among studies. Meta-analyses were performed for seven risk factors. Significant differences for the odds of developing sleep disturbances were found for hot flashes (pooled OR (ORp) 2.25, 95% CI = [1.64–3.08], I2 = 0%, p = 0.90), race (ORp 2.31, 95% CI = [1.56–3.42], I2 = 0%, p = 0.47), and menopause (ORp 1.84, 95% CI = [1.11–3.06], I2 = 0%, p = 0.70). After withdrawing the studies that did not rely on the use of a measurement tool with strong psychometric properties, pain (ORp 2.31, 95% CI = [1.36–3.92], I2 = 27%, p = 0.25), depressive symptoms (ORp 3.20, 95% CI [2.32–4.42], I2 = 0%, p = 0.63), and fatigue (ORp 2.82, 95% CI = [1.98–4.02], I2 = 0%, p = 0.60) became significant as well, with a substantial decrease of heterogeneity.

Conclusion

Prevalence for sleep disturbances ranged from 0.14 to 0.93 with the vast majority of the studies investigating insomnia and sleep-wake disturbances. High heterogeneity makes it difficult to draw firm conclusions. Pain, depressive symptoms, hot flashes, fatigue, non-Caucasian race, and menopausal status were significantly associated with increased odds for developing sleep disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fitzmaurice C et al (2016) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol

  2. Coleman MP, Quaresma M, Berrino F, Lutz JM, de Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL, CONCORD Working Group (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9(8):730–756

    Article  PubMed  Google Scholar 

  3. Roth T (2007) Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med 3(5 Suppl):S7–S10

    PubMed  PubMed Central  Google Scholar 

  4. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders-IV-TR. American Psychiatric Association, Washington, DC

    Google Scholar 

  5. Colten H, Altevogt B (2006) Sleep disorders and sleep deprivation: an unmet public health problem, vol 2007. National Academies Press, Washington, DC

    Google Scholar 

  6. Janz NK et al (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health 16(9):1348–1361

    Article  Google Scholar 

  7. Reinsel RA, Starr TD, O'Sullivan B, Passik SD, Kavey NB (2015) Polysomnographic study of sleep in survivors of breast Cancer. J Clin Sleep Med 11(12):1361–1370

    Article  PubMed  PubMed Central  Google Scholar 

  8. Jim HS et al (2013) Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy. Health Psychol 32(7):768–774

    Article  PubMed  PubMed Central  Google Scholar 

  9. Daley M et al (2009) The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 32(1):55–64

    PubMed  PubMed Central  Google Scholar 

  10. Morin CM (1993) Insomnia: psychological assessment and management. Guilford Press

  11. Savard J et al (2001) Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24(5):583–590

    Article  CAS  PubMed  Google Scholar 

  12. Hoffman KE et al (2009) Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 169(14):1274–1281

    Article  PubMed  Google Scholar 

  13. Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D (2013) Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum 40(1):35–42

    Article  PubMed  Google Scholar 

  14. Waters EA et al (2013) Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients. Ann Behav Med 45(1):57–68

    Article  PubMed  Google Scholar 

  15. Berrett-Abebe J et al (2015) Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol 33(3):297–309

    Article  PubMed  Google Scholar 

  16. Irvine DM, Vincent L, Graydon JE, Bubela N (1998) Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 21(2):127–135

    Article  CAS  PubMed  Google Scholar 

  17. Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR (2010) Prevalence, demographics, and psychological associations of sleep disruption in patients with Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program. J Clin Oncol 28(2):292–298

    Article  PubMed  Google Scholar 

  18. Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34

    Article  PubMed  Google Scholar 

  19. Office of Cancer Survivorship, NCI About cancer survivorship research: survivorship definitions. 2012. Available from: http://cancercontrol.cancer.gov/ocs/researcher_factsheet.pdf

  20. Elmagarmid A et al (2014) Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. In: Evidence-informed public health: opportunities and challenges. Abstracts of the 22nd Cochrane Colloquium. Wiley, Hyderabad

    Google Scholar 

  21. Green, S., et al., Chapter 1: what is a systematic review. Cochrane handbook for systematic reviews of interventions version, 2008. 5(0)

    Google Scholar 

  22. Dahl AA et al (2011) Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations. Sleep Med 12(6):584–590

    Article  PubMed  Google Scholar 

  23. Kim SH et al (2008) Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manag 35(6):644–655

    Article  Google Scholar 

  24. Klyushnenkova EN, Sorkin JD, Gallicchio L (2015) Association of obesity and sleep problems among breast cancer survivors: results from a registry-based survey study. Support Care Cancer 23(12):3437–3445

    Article  PubMed  PubMed Central  Google Scholar 

  25. Otte JL et al (2010) Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manag 39(3):535–547

    Article  Google Scholar 

  26. Modesti PA et al (2016) Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One 11(1):e0147601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. McPheeters ML et al (2012) Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities). Evid Rep Technol Assess (Full Rep) (208.3):1–475

    Google Scholar 

  28. Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  PubMed Central  Google Scholar 

  29. Deeks JJ, Higgins J, Altman DG (2008) Analysing data and undertaking meta-analyses. In: Cochrane handbook for systematic reviews of interventions: Cochrane book series, pp 243–296

    Chapter  Google Scholar 

  30. Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Desai K, Mao JJ, Su I, DeMichele A, Li Q, Xie SX, Gehrman PR (2013) Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer 21(1):43–51

    Article  PubMed  Google Scholar 

  32. Ahn SH et al (2007) Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 18(1):173–182

    Article  CAS  PubMed  Google Scholar 

  33. Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, Bernstein L, Baumgartner KB, Ballard-Barbash R (2011) Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat 130(1):243–254

    Article  PubMed  PubMed Central  Google Scholar 

  34. Arraras JI et al (2016) Quality of life in long-term premenopausal early-stage breast cancer survivors from Spain. Effects of surgery and time since surgery. J Buon 21(5):1090–1098

    Google Scholar 

  35. Berger AM et al (2012) Usual and worst symptom severity and interference with function in breast cancer survivors. J Support Oncol 10(3):112–118

    Article  PubMed  Google Scholar 

  36. Couzi RJ, Helzlsouer KJ, Fetting JH (1995) Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13(11):2737–2744

    Article  CAS  PubMed  Google Scholar 

  37. Forsythe L et al (2012) Daytime sleepiness and sleep duration in long-term cancer survivors and non-cancer controls: results from a registry-based survey study. Support Care Cancer 20(10):2425–2432

    Article  PubMed  Google Scholar 

  38. Gonzalez BD, Lu Q (2018) Sleep disturbance among Chinese breast cancer survivors living in the USA. Support Care Cancer 26(6):1695–1698

    Article  PubMed  PubMed Central  Google Scholar 

  39. Heins MJ et al (2013) For which health problems do cancer survivors visit their general practitioner? Eur J Cancer 49(1):211–218

    Article  CAS  PubMed  Google Scholar 

  40. Kluthcovsky A et al (2012) Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer 20(8):1901–1909

    Article  Google Scholar 

  41. Lee ES et al (2011) Health-related quality of life in survivors with breast cancer 1 year after diagnosis compared with the general population a prospective cohort study. Ann Surg 253(1):101–108

    Article  PubMed  Google Scholar 

  42. Lowery-Allison AE et al (2017) Sleep problems in breast cancer survivors 1-10 years posttreatment. Palliat Support Care:1–10

  43. Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE (2017) Sleep duration and breast cancer prognosis: perspectives from the Women's healthy eating and living study. Breast Cancer Res Treat 162(3):581–589

    Article  PubMed  PubMed Central  Google Scholar 

  44. Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011) Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res 71(3):136–141

    Article  PubMed  Google Scholar 

  45. Palmer SC et al (2016) Symptoms, unmet need, and quality of life among recent breast cancer survivors. J Community Support Oncol 14(7):299–306

    Article  Google Scholar 

  46. Schultz PN et al (2005) Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs 14(2):204–211

    Article  PubMed  Google Scholar 

  47. Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13(4):589–598

    Article  CAS  PubMed  Google Scholar 

  48. Taylor TR et al (2012) Understanding sleep disturbances in African-American breast cancer survivors: a pilot study. Psycho-Oncology 21(8):896–902

    Article  PubMed  Google Scholar 

  49. Yang EJ, Kim BR, Shin HI, Lim JY (2012) Use of the international classification of functioning, disability and health as a functional assessment tool for breast cancer survivors. J Breast Cancer 15(1):43–50

    Article  PubMed  PubMed Central  Google Scholar 

  50. Zucca AC, Boyes AW, Linden W, Girgis A (2012) All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types. J Pain Symptom Manag 43(4):720–731

    Article  Google Scholar 

  51. Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5):1387–1394

    Article  PubMed  Google Scholar 

  52. Fiorentino L, Ancoli-Israel S (2006) Insomnia and its treatment in women with breast cancer. Sleep Med Rev 10(6):419–429

    Article  PubMed  PubMed Central  Google Scholar 

  53. Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908

    Article  CAS  PubMed  Google Scholar 

  54. Palesh O, Aldridge-Gerry A, Zeitzer JM, Koopman C, Neri E, Giese-Davis J, Jo B, Kraemer H, Nouriani B, Spiegel D (2014) Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 37(5):837–842

    Article  PubMed  PubMed Central  Google Scholar 

  55. Galiano-Castillo N, Arroyo-Morales M, Ariza-Garcia A, Fernández-Lao C, Fernández-Fernández AJ, Cantarero-Villanueva I (2017) Factors that explain the cancer-related insomnia. Breast J 23(4):387–394

    Article  PubMed  Google Scholar 

  56. Jansson-Frojmark M, Lindblom K (2008) A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res 64(4):443–449

    Article  PubMed  Google Scholar 

  57. Morphy H et al (2007) Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 30(3):274–280

    PubMed  Google Scholar 

  58. Johnson EO, Roth T, Breslau N (2006) The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 40(8):700–708

    Article  PubMed  Google Scholar 

  59. Ohayon MM, Roth T (2003) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37(1):9–15

    Article  PubMed  Google Scholar 

  60. Carpenter JS, Elam JL, Ridner SH, Carney PH, Cherry GJ, Cucullu HL (2004) Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31(3):591–5598

    Article  PubMed  Google Scholar 

  61. Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? Jama 262(11):1479–1484

    Article  CAS  PubMed  Google Scholar 

  62. Ell K et al (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecological cancer. J Clin Oncol Off J Am Soc Clin Oncol 23(13):3052

    Article  Google Scholar 

  63. Forsythe LP, Alfano CM, George SM, McTiernan A, Baumgartner KB, Bernstein L, Ballard-Barbash R (2013) Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 137(2):617–630

    Article  PubMed  Google Scholar 

  64. Anders CK et al (2009) Breast cancer before age 40 years. Semin Oncol 36(3):237–249

    Article  PubMed  PubMed Central  Google Scholar 

  65. Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E (2007) Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from international breast Cancer study group trials V and VI. Eur J Cancer 43(11):1646–1653

    Article  PubMed  Google Scholar 

  66. Rapkin AJ (2007) Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol 196(2):97–106

    Article  PubMed  Google Scholar 

  67. Kronenberg F (1990) Hot flashes: epidemiology and physiologya. Ann N Y Acad Sci 592(1):52–86

    Article  CAS  PubMed  Google Scholar 

  68. Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, van Limbergen E, Carbonez A, van Huffel S, Ameye L, Paridaens R (2004) Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti-Cancer Drugs 15(8):753–760

    Article  CAS  PubMed  Google Scholar 

  69. Abrahams HJG, Gielissen MFM, Verhagen CAHHVM, Knoop H (2018) The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: a systematic review. Clin Psychol Rev 63:1–11

    Article  CAS  PubMed  Google Scholar 

  70. Rumble ME, Keefe FJ, Edinger JD, Affleck G, Marcom PK, Shaw HS (2010) Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast Cancer survivors: a daily process analysis. Sleep 33(11):1501–1509

    Article  PubMed  PubMed Central  Google Scholar 

  71. Dudley KA, Patel SR (2016) Disparities and genetic risk factors in obstructive sleep apnea. Sleep Med 18:96–102

    Article  PubMed  Google Scholar 

  72. Beatty DL, Hall MH, Kamarck TA, Buysse DJ, Owens JF, Reis SE, Mezick EJ, Strollo PJ, Matthews KA (2011) Unfair treatment is associated with poor sleep in African American and Caucasian adults: Pittsburgh SleepSCORE project. Health Psychol 30(3):351–359

    Article  PubMed  PubMed Central  Google Scholar 

  73. Hall M, Bromberger J, Matthews K (1999) Socioeconomic status as a correlate of sleep in African-American and Caucasian women. Ann N Y Acad Sci 896(1):427–430

    Article  CAS  PubMed  Google Scholar 

  74. Jüni P et al (2002) Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 31(1):115–123

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Beckwée.

Ethics declarations

Conflict of interest

The authors have full control of all data acquired from included manuscripts and agree to allow the journal to review the data if requested.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Laurence Leysen and Astrid Lahousse share first authorship

Appendices

Appendix 1

Table 4 Search terms

Appendix 2

Fig. 3
figure 3

Prevalence of sleep disturbances in breast cancer survivors

Appendix 3: Methodological quality

Fig. 4
figure 4

NOS < 7

Fig. 5
figure 5

NOS ≥ 7

Appendix 4: Study design

Fig. 6
figure 6

Longitudinal studies

Fig. 7
figure 7

Cross-sectional studies

Appendix 5: Type of sleep disturbance

Fig. 8
figure 8

Sleep-wake disturbance + sleep difficulty

Fig. 9
figure 9

Insomnia

Fig. 10
figure 10

Short sleepers

Appendix 6

Fig. 11
figure 11

Validated measurement tool

Appendix 7: Pain

Fig. 12
figure 12

Pain before subgroup analysis

Fig. 13
figure 13

Pain after subgroup analysis

Appendix 8: Depressive symptoms

Fig. 14
figure 14

Depressive symptoms before subgroup analysis

Fig. 15
figure 15

Depressive symptoms after subgroup analysis

Appendix 9

Fig. 16
figure 16

Hot flashes

Appendix 10: Fatigue

Fig. 17
figure 17

Fatigue before subgroup analysis

Fig. 18
figure 18

Fatigue after subgroup analysis

Appendix 11

Fig. 19
figure 19

Anxiety

Appendix 12

Fig. 20
figure 20

Race

Appendix 13

Fig. 21
figure 21

Menopause

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leysen, L., Lahousse, A., Nijs, J. et al. Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses. Support Care Cancer 27, 4401–4433 (2019). https://doi.org/10.1007/s00520-019-04936-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-04936-5

Keywords

Navigation